CCI imposes over Rs 74 cr penalty on pharma companies, trade bodies


The Competition Commission of India (CCI) has imposed penalties of over Rs 74 crore on two pharmaceutical companies — Himalaya Drug Company and Intas Pharmaceuticals — as well as two Madhya Pradesh-based drug associations for indulging in anti-competitive trade practices, an official release said on Thursday.

The CCI found activities of Madhya Pradesh Chemists and Druggist Association (MPCDA) and Indore Chemists Association (ICA) to be in contravention of the provisions of the Competition Act, 2002.

As per the CCI order on June 3, a penalty of Rs 55.59 crore was levied on Intas Pharmaceuticals while Himalaya Drug was fined Rs 18.59 crore. Penalties were also imposed on certain officials of these firms.

Besides, MPCDA was fined Rs 4.18 lakh and ICA Rs 39,812.